Fram Buhari, MD
Cardiovascular Disease (Cardiology) · Stockton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 57 years
- Graduated 1969
Offices
1 location · San Joaquin Cardiology Medical Group Inc · 7 clinicians in this group
Hospitals listed: Dameron Hospital · St Joseph'S Medical Center of Stockton. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Buhari’s office at (209) 464-7681 to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Dameron HospitalStockton, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 2 of 5 · 58% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — MRSA Bacteremia: 18.373, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- St Joseph'S Medical Center of StocktonStockton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 67% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.08, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.34, Oct 2024 – Sep 2025
See every measure and the patient survey for Dameron Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| MRSA BacteremiaInfections | 18.373 | Worse | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.46 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.1 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.5 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.5 · 75 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.5 · 121 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.8 · 41 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,121 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.52) · 1,225 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.06 (0.59 to 5.54) · 371 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.34) · 116 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.41 (0.76 to 4.05) · 363 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.35 (0.5 to 18.2) · 123 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.94 (0.72 to 9.16) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.36 (0 to 1.37) · 1,066 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.678 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 118 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 144 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 41.3 · 92 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 5.5 · 89 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 22.9 · 118 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 178 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.2 · 44 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 78 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.6 to 17.2) · 386 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.5) · 261 cases | No different | Jan 2024 – Dec 2024 |
What patients said (385 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 1 |
| Communication about medicines | 1 |
| Discharge information | 1 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 66% |
| Staff "always" explained | 49% |
| Yes, staff "did" give patients this information | 77% |
| Yes, staff "did" give patients information about help after discharge | 72% |
| Doctors "always" explained things so they could understand | 62% |
| Doctors "always" listened carefully | 63% |
| Doctors "always" treated them with courtesy and respect | 74% |
| Patients who gave a rating of "9" or "10" (high) | 55% |
| Staff "always" explained new medications | 61% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 58% |
| Staff "always" explained possible side effects | 37% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for St Joseph'S Medical Center of Stockton
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.08 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.34 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.51 (0.54 to 2.47) · 1,424 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.78 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.22 (98.08 to 180.36) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 127 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 98 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.9 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.2 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.4 · 405 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9 · 337 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,812 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.09 to 0.49) · 6,528 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,304 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.48 (1.49 to 5.48) · 1,467 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.27 (0 to 2.79) · 464 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.22 (0.81 to 3.64) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.16 (1.3 to 13.02) · 455 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.22 (1.5 to 8.93) · 456 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.24 (0.78 to 3.71) · 262 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.03 (0.53 to 1.53) · 6,521 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.537 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.486 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.646 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 484 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 878 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.2 · 265 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 17.1 · 493 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 407 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 615 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.1 · 184 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 164 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 290 cases | No different | Jan 2024 – Dec 2024 |
What patients said (541 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$453,036
Medicare paid this office $453,036 for 701 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 493 | $63,770 | $94 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 50 | $60,273 | $1,205 |
| Injection, inclisiran, 1 mg | 14 | $59,596 | None |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 50 | $40,787 | $408 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 23 | $25,035 | $1,088 |
See all 39 services
| Return visit (30+ min) | 493 | $63,770 | $94 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 50 | $60,273 | $1,205 |
| Injection, inclisiran, 1 mg | 14 | $59,596 | None |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 50 | $40,787 | $408 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 23 | $25,035 | $1,088 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 25 | $17,046 | $682 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 96 | $15,497 | $157 |
| Ultrasound of leg arteries or artery grafts | 38 | $7,561 | $199 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 82 | $5,369 | $58 |
| New patient visit (60+ min) | 33 | $5,059 | $153 |
| Ultrasound of both sides of head and neck blood flow | 27 | $3,973 | $147 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $3,910 | $355 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 321 | $3,903 | $10 |
| Transitional care management services for problem of high complexity | 17 | $3,884 | $228 |
| Programming of dual lead pacemaker system | 33 | $3,309 | $59 |
| Complete ultrasound study of arm and leg arteries | 32 | $3,141 | $98 |
| Programming of single lead pacemaker system | 46 | $3,019 | $48 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 15 | $2,846 | $38 |
| Programming of dual lead implantable defibrillator system | 18 | $2,634 | $80 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 13 | $2,541 | $37 |
| Review by radiologist of abdominal aorta image | 24 | $2,450 | $102 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 110 | $2,165 | $19 |
| Review by radiologist of pelvis artery image | 17 | $2,017 | $119 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 11 | $1,677 | $76 |
| Review by radiologist of additional artery image | 19 | $1,503 | $79 |
| Injection, regadenoson, 0.1 mg | 60 | $1,273 | None |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 30 | $1,264 | $42 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 26 | $1,230 | $47 |
| Short return visit (20+ min) | 16 | $1,150 | $72 |
| Heart muscle strain imaging | 28 | $896 | $31 |
| Programming of cardiac rhythm monitor system | 11 | $792 | $47 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 31 | $723 | $17 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 21 | $597 | $21 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 28 | $568 | $0 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $429 | $27 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 32 | $417 | $13 |
| Injection of drug or substance under skin or into muscle | 14 | $259 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $186 | $9 |
| Injection, midazolam hydrochloride, per 1 mg | 28 | $4 | None |
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
| Leg revascularization (restoring blood flow) | 21 | More than 74% of doctors who do this |
| Pacemaker insertion or repair | 1-10 | None |
Procedures year by year
| Procedure | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 22 | 25 | – | – | – | 23 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | – | 25 | – | – | – | – |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | – | 25 | – | – | – | – |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | – | 14 | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
701 Original Medicare patients in 2024. Average age 75 · Under 65 9% · 85 and older 14% · Women 47% · Also on Medicaid 37% · Health risk score 1.66. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 55% · Diabetes 50% · Chronic kidney disease 38% · Heart failure 35% · Atrial fibrillation 35% · COPD 20% · Depression 16% · Cancer 13% · Stroke 13% · Dementia 7%.
The office billed $1,470,416, Medicare allowed $584,194 and paid $453,036; for 14,399 services of 84 kinds; $61,526 of it was for drugs given in the office and $391,510 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 701 | 14,399 | 75 | 1.66 | $1,470,416 | $453,036 |
| 2023 | 665 | 3,622 | 74 | 1.70 | $813,893 | $261,542 |
| 2022 | 722 | 4,165 | 74 | 1.55 | $927,208 | $312,971 |
| 2021 | 72 | 127 | 72 | 1.53 | $29,492 | $10,332 |
| 2019 | 881 | 9,388 | 74 | 1.98 | $2,593,250 | $844,075 |
| 2018 | 1,269 | 12,653 | 73 | 1.81 | $3,494,960 | $1,090,976 |
| 2017 | 1,161 | 5,624 | 73 | 2.00 | $2,309,989 | $667,612 |
| 2016 | 1,390 | 7,177 | 74 | 2.05 | $2,060,063 | $644,777 |
| 2015 | 1,550 | 7,308 | 74 | 2.02 | $1,798,005 | $674,646 |
| 2014 | 1,451 | 7,589 | 74 | 1.80 | $1,766,312 | $658,291 |
| 2013 | 1,435 | 8,816 | 74 | 1.76 | $1,887,615 | $749,169 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Return visit (30+ min) | 518 | $58,645 | $89 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 40 | $48,778 | $1,219 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 40 | $32,629 | $408 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 20 | $14,305 | $715 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $9,951 | $149 |
| Injection, regadenoson, 0.1 mg | 44 | $7,342 | None |
| New patient visit (60+ min) | 30 | $4,124 | $137 |
| Ultrasound of both sides of head and neck blood flow | 22 | $3,521 | $160 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 59 | $3,503 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 309 | $3,350 | $10 |
| Ultrasound of leg arteries or artery grafts | 14 | $2,854 | $204 |
| Programming of single lead pacemaker system | 43 | $2,601 | $50 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,389 | $199 |
| Programming of dual lead pacemaker system | 22 | $1,953 | $53 |
| Programming of dual lead implantable defibrillator system | 16 | $1,725 | $78 |
| Complete ultrasound study of arm and leg arteries | 13 | $1,389 | $107 |
| Short return visit (20+ min) | 19 | $1,310 | $69 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 18 | $966 | $54 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 17 | $943 | $55 |
| Programming of cardiac rhythm monitor system | 15 | $816 | $51 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 15 | $303 | $20 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | $213 | $10 |
2022: 27 services
| Return visit (30+ min) | 538 | $73,622 | $98 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 41 | $51,204 | $1,249 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 41 | $34,213 | $417 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 80 | $13,316 | $166 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 15 | $11,453 | $764 |
| Injection, regadenoson, 0.1 mg | 51 | $9,942 | None |
| Ultrasound of leg arteries or artery grafts | 42 | $8,961 | $208 |
| Ultrasound of both sides of head and neck blood flow | 32 | $5,272 | $165 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 375 | $4,884 | $11 |
| New patient visit (60+ min) | 29 | $4,715 | $163 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 67 | $4,464 | $58 |
| Complete ultrasound study of arm and leg arteries | 39 | $4,171 | $107 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $4,014 | $365 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 52 | $2,935 | $55 |
| Short return visit (20+ min) | 31 | $2,325 | $75 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 41 | $2,200 | $54 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 13 | $2,147 | $165 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 11 | $2,123 | $193 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,938 | $161 |
| Programming of dual lead pacemaker system | 23 | $1,892 | $63 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 11 | $1,816 | $83 |
| New patient visit (45+ min) | 15 | $1,763 | $118 |
| Long return visit (40+ min) | 11 | $1,655 | $150 |
| Programming of single lead pacemaker system | 27 | $1,645 | $53 |
| Programming of dual lead implantable defibrillator system | 13 | $1,233 | $73 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 16 | $275 | $17 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 27 | $275 | $10 |
2021: 2 services
| Return visit (30+ min) | 60 | $6,884 | $108 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 37 | $474 | $12 |
2019: 45 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 116 | $145,462 | $1,243 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 120 | $99,030 | $414 |
| Return visit (30+ min) | 476 | $55,568 | $76 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 205 | $34,761 | $166 |
| Injection, regadenoson, 0.1 mg | 130 | $23,787 | None |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 25 | $23,762 | $950 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 12 | $15,310 | $1,094 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 181 | $12,997 | $58 |
| Ultrasound of leg arteries or artery grafts | 52 | $12,404 | $218 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 16 | $9,565 | $598 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $9,358 | $85 |
| Ultrasound of both sides of head and neck blood flow | 52 | $8,701 | $167 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 34 | $7,185 | $200 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,857 | $429 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $5,595 | $60 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 84 | $5,372 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,295 | $165 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 12 | $5,010 | $385 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 72 | $4,957 | $68 |
| Short return visit (20+ min) | 95 | $4,907 | $48 |
| Transitional care management services for problem of high complexity | 22 | $4,635 | $193 |
| Complete ultrasound study of arm and leg arteries | 42 | $4,630 | $110 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 11 | $4,142 | $166 |
| Review by radiologist of both arms or legs arteries image | 27 | $4,025 | $149 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 23 | $3,934 | $164 |
| Review by radiologist of pelvis artery image | 28 | $3,810 | $131 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 256 | $3,782 | $13 |
| Programming of dual lead implantable defibrillator system | 40 | $3,723 | $60 |
| Review by radiologist of additional artery image | 22 | $3,178 | $71 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 24 | $3,085 | $123 |
| Review by radiologist of abdominal aorta image | 27 | $2,995 | $111 |
| Programming of dual lead pacemaker system | 45 | $2,519 | $46 |
| New patient visit (60+ min) | 16 | $2,403 | $150 |
| New patient visit (45+ min) | 14 | $1,574 | $112 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 29 | $1,441 | $44 |
| Programming of single lead pacemaker system | 30 | $1,258 | $41 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 27 | $727 | $9 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 60 | $686 | $10 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 27 | $472 | $0 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 14 | $437 | $19 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 19 | $345 | $18 |
| Programming of cardiac rhythm monitor system | 11 | $328 | $30 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 11 | $127 | $10 |
| Infusion, normal saline solution, 250 cc | 130 | $65 | None |
| Injection, midazolam hydrochloride, per 1 mg | 29 | $7 | None |
2018: 46 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 177 | $217,488 | $1,215 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 175 | $130,309 | $368 |
| Return visit (30+ min) | 633 | $86,153 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 311 | $54,410 | $167 |
| Injection, regadenoson, 0.1 mg | 185 | $33,015 | None |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 22 | $24,025 | $1,092 |
| Ultrasound of leg arteries or artery grafts | 102 | $22,362 | $217 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 121 | $22,148 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 133 | $20,291 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $18,384 | $84 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 255 | $17,578 | $57 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 30 | $15,971 | $410 |
| Ultrasound of both sides of head and neck blood flow | 90 | $15,384 | $169 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 78 | $14,791 | $185 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 222 | $13,580 | $59 |
| Complete ultrasound study of arm and leg arteries | 102 | $11,796 | $112 |
| Transitional care management services for problem of high complexity | 49 | $11,113 | $192 |
| Short return visit (20+ min) | 147 | $8,809 | $56 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 123 | $8,491 | $66 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 51 | $8,293 | $163 |
| New patient visit (60+ min) | 46 | $7,084 | $154 |
| Critical care, first 30-74 minutes | 26 | $7,001 | $175 |
| Programming of dual lead implantable defibrillator system | 44 | $4,981 | $53 |
| Review by radiologist of both arms or legs arteries image | 30 | $4,848 | $162 |
| Programming of dual lead pacemaker system | 65 | $4,083 | $40 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 262 | $4,002 | $13 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 16 | $3,824 | $225 |
| Review by radiologist of additional artery image | 28 | $3,803 | $73 |
| Review by radiologist of pelvis artery image | 28 | $3,739 | $134 |
| Review by radiologist of abdominal aorta image | 27 | $3,053 | $113 |
| Programming of single lead pacemaker system | 33 | $2,051 | $39 |
| Follow-up observation care per day, typically 35 minutes | 14 | $1,957 | $85 |
| Long return visit (40+ min) | 20 | $1,905 | $87 |
| New patient visit (45+ min) | 15 | $1,877 | $125 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 37 | $1,694 | $43 |
| Long return visit (40+ min) | 13 | $1,427 | $110 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 125 | $1,403 | $10 |
| New patient visit (30+ min) | 11 | $969 | $88 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 31 | $796 | $9 |
| Programming of cardiac rhythm monitor system | 16 | $765 | $32 |
| Injection for imaging of aorta above heart valve with review by radiologist | 17 | $751 | $42 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 33 | $586 | $0 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 12 | $327 | $16 |
| Injection, aminophyllin, up to 250 mg | 47 | $265 | None |
| Infusion, normal saline solution, 250 cc | 185 | $89 | None |
| Injection, midazolam hydrochloride, per 1 mg | 26 | $4 | None |
2017: 35 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 143 | $170,876 | $1,178 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 143 | $65,993 | $228 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 305 | $57,695 | $184 |
| Return visit (30+ min) | 455 | $54,847 | $80 |
| Injection, regadenoson, 0.1 mg | 222 | $39,684 | None |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 84 | $35,577 | $409 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 294 | $22,228 | $58 |
| Ultrasound of leg arteries or artery grafts | 102 | $21,640 | $212 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 84 | $16,507 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $14,446 | $164 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 267 | $13,968 | $50 |
| Ultrasound of both sides of head and neck blood flow | 85 | $13,793 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 96 | $12,153 | $58 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $11,641 | $431 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 54 | $11,088 | $202 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 55 | $9,257 | $165 |
| New patient visit (60+ min) | 55 | $8,252 | $150 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 97 | $6,854 | $69 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 28 | $6,096 | $218 |
| Complete ultrasound study of arm and leg arteries | 46 | $5,157 | $110 |
| Programming of dual lead implantable defibrillator system | 47 | $4,816 | $55 |
| Programming of dual lead pacemaker system | 64 | $4,470 | $42 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $4,315 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 270 | $4,078 | $13 |
| Short return visit (20+ min) | 40 | $2,143 | $54 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 25 | $1,594 | $64 |
| Programming of single lead pacemaker system | 21 | $1,210 | $38 |
| Injection for imaging of aorta above heart valve with review by radiologist | 26 | $1,093 | $42 |
| Long return visit (40+ min) | 11 | $991 | $90 |
| Injection, aminophyllin, up to 250 mg | 155 | $986 | None |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 75 | $791 | $10 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 12 | $342 | $29 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 18 | $327 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 18 | $219 | $12 |
| Infusion, normal saline solution, 250 cc | 222 | $90 | None |
2016: 41 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 264 | $109,525 | $409 |
| Return visit (30+ min) | 518 | $65,151 | $81 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 300 | $57,119 | $183 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 264 | $50,803 | $95 |
| Injection, regadenoson, 0.1 mg | 264 | $45,001 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 236 | $43,787 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 193 | $35,124 | $163 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 440 | $23,677 | $51 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 334 | $22,112 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $20,559 | $84 |
| Ultrasound of both sides of head and neck blood flow | 123 | $18,825 | $148 |
| Ultrasound of leg arteries or artery grafts | 93 | $15,171 | $160 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 72 | $14,699 | $204 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 26 | $13,883 | $448 |
| New patient visit (60+ min) | 58 | $9,341 | $161 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 47 | $7,098 | $151 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 94 | $6,460 | $66 |
| Short return visit (20+ min) | 102 | $6,001 | $55 |
| Critical care, first 30-74 minutes | 24 | $5,583 | $180 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 338 | $5,374 | $13 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 17 | $4,673 | $246 |
| Programming of dual lead implantable defibrillator system | 34 | $4,036 | $58 |
| Programming of dual lead pacemaker system | 58 | $3,697 | $43 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 39 | $2,654 | $65 |
| Follow-up observation care per day, typically 35 minutes | 16 | $2,380 | $85 |
| Insertion of tube into aorta | 15 | $1,857 | $124 |
| New patient visit (45+ min) | 12 | $1,499 | $125 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 28 | $1,452 | $50 |
| Long return visit (40+ min) | 14 | $1,424 | $102 |
| Test to examine how well the lungs exchange gases | 31 | $1,359 | $42 |
| Review by radiologist of abdominal aorta and both leg arteries image | 17 | $1,213 | $71 |
| Test to determine lung volumes using gas dilution or washout | 31 | $1,137 | $36 |
| Injection for imaging of aorta above heart valve with review by radiologist | 17 | $841 | $42 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 13 | $720 | $45 |
| Programming of single lead pacemaker system | 13 | $659 | $37 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 29 | $565 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 17 | $520 | $29 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 29 | $368 | $12 |
| Administration of influenza virus vaccine | 13 | $345 | $27 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 12 | $191 | $16 |
| Infusion, normal saline solution, 250 cc | 264 | $100 | None |
2015: 38 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 435 | $83,787 | $187 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 191 | $79,029 | $412 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 349 | $60,443 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 312 | $57,983 | $165 |
| Return visit (30+ min) | 503 | $56,712 | $81 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 188 | $49,967 | $132 |
| Injection, regadenoson, 0.1 mg | 188 | $31,394 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 124 | $27,958 | $84 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 440 | $23,901 | $51 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 104 | $22,947 | $216 |
| Short return visit (20+ min) | 311 | $19,976 | $53 |
| Ultrasound of both sides of head and neck blood flow | 131 | $19,431 | $146 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 284 | $18,632 | $54 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 32 | $17,031 | $448 |
| New patient visit (60+ min) | 68 | $11,080 | $163 |
| Complete ultrasound study of arm and leg arteries | 37 | $8,243 | $114 |
| Ultrasound of leg arteries or artery grafts | 39 | $7,249 | $186 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 28 | $7,173 | $256 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 96 | $6,803 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 353 | $5,439 | $13 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $4,570 | $415 |
| Programming of dual lead pacemaker system | 61 | $4,247 | $45 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 25 | $4,157 | $160 |
| Programming of dual lead implantable defibrillator system | 25 | $2,992 | $59 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 43 | $2,857 | $65 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 50 | $2,478 | $50 |
| Critical care, first 30-74 minutes | 12 | $2,172 | $181 |
| Test to examine how well the lungs exchange gases | 51 | $2,169 | $43 |
| Test to determine lung volumes using gas dilution or washout | 51 | $1,796 | $35 |
| Follow-up observation care per day, typically 35 minutes | 12 | $1,795 | $85 |
| Insertion of tube into aorta | 11 | $1,369 | $124 |
| Injection for imaging of aorta above heart valve with review by radiologist | 29 | $1,220 | $42 |
| Long return visit (40+ min) | 11 | $1,142 | $104 |
| Programming of single lead pacemaker system | 13 | $738 | $41 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 37 | $693 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 17 | $563 | $31 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 37 | $452 | $12 |
| Infusion, normal saline solution, 250 cc | 189 | $60 | None |
2014: 31 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 206 | $84,976 | $407 |
| Return visit (30+ min) | 645 | $76,225 | $75 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 366 | $70,187 | $184 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 208 | $55,502 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 327 | $51,540 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 265 | $48,273 | $162 |
| Injection, regadenoson, 0.1 mg | 207 | $34,759 | None |
| Short return visit (20+ min) | 479 | $34,664 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 101 | $25,005 | $84 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 301 | $21,326 | $54 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 402 | $21,079 | $51 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 89 | $19,414 | $216 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $12,658 | $452 |
| New patient visit (60+ min) | 73 | $10,895 | $149 |
| Ultrasound of both sides of head and neck blood flow | 70 | $9,805 | $140 |
| Ultrasound of leg arteries or artery grafts | 43 | $8,386 | $186 |
| Complete ultrasound study of arm and leg arteries | 41 | $8,202 | $112 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 28 | $7,007 | $242 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 404 | $6,030 | $13 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 50 | $3,358 | $65 |
| Programming of dual lead pacemaker system | 52 | $3,342 | $43 |
| Long return visit (40+ min) | 24 | $2,085 | $87 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 27 | $1,842 | $66 |
| Programming of dual lead implantable defibrillator system | 20 | $1,781 | $52 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 25 | $1,247 | $50 |
| Test to examine how well the lungs exchange gases | 25 | $1,143 | $46 |
| Injection for imaging of aorta above heart valve with review by radiologist | 25 | $1,031 | $40 |
| Test to determine lung volumes using gas dilution or washout | 25 | $881 | $35 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 42 | $792 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 42 | $522 | $12 |
| Infusion, normal saline solution, 250 cc | 205 | $53 | None |
2013: 35 services
| Return visit (30+ min) | 756 | $107,163 | $76 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 244 | $103,247 | $416 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 374 | $66,181 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 354 | $64,420 | $55 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 241 | $64,007 | $131 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 369 | $56,037 | $148 |
| Short return visit (20+ min) | 551 | $48,565 | $56 |
| Injection, regadenoson, 0.1 mg | 239 | $40,492 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 107 | $27,805 | $80 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 316 | $24,083 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 430 | $21,645 | $48 |
| New patient visit (60+ min) | 107 | $15,716 | $147 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 61 | $13,486 | $214 |
| Ultrasound of both sides of head and neck blood flow | 77 | $11,816 | $153 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 40 | $10,202 | $249 |
| Ultrasound of leg arteries or artery grafts | 60 | $10,067 | $162 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $7,768 | $457 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 355 | $5,573 | $14 |
| Complete ultrasound study of arm and leg arteries | 47 | $5,377 | $108 |
| Programming of dual lead pacemaker system | 41 | $2,743 | $44 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 36 | $2,637 | $69 |
| Long return visit (40+ min) | 22 | $2,528 | $115 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 40 | $2,452 | $61 |
| Programming of dual lead implantable defibrillator system | 20 | $1,964 | $58 |
| Ultrasound of leg arteries at rest and after exercise | 11 | $1,640 | $149 |
| Injection for imaging of aorta above heart valve with review by radiologist | 30 | $1,133 | $38 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 14 | $744 | $53 |
| Test to examine how well the lungs exchange gases | 14 | $726 | $52 |
| Test to determine lung volumes using gas dilution or washout | 14 | $549 | $39 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 30 | $534 | $17 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 14 | $359 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 30 | $355 | $11 |
| Smoking and tobacco use intensive counseling, more than 10 minutes | 14 | $320 | $21 |
| Iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta | 12 | $114 | $10 |
| Infusion, normal saline solution, 250 cc | 238 | $55 | None |
Medicaid work
$32,321 in 2024
Medicaid paid $32,321 for 739 billed services this clinician did in 2024, up to 64 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 398 | $17,281 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 238 | $6,492 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 24 | $5,041 |
| CARDIOVASCULAR STRESS TEST | 26 | $2,307 |
| XTRNL MOBILE CV TELEMETRY W/I&REPORT 30 DAYS | 53 | $1,199 |
| 2024 | 739 | 5 | 64 | $32,321 |
| 2023 | 854 | 3 | 88 | $36,496 |
| 2022 | 783 | 5 | 56 | $34,082 |
| 2021 | 52 | 2 | 19 | $2,150 |
| 2019 | 1,722 | 14 | 77 | $128,314 |
| 2018 | 2,409 | 14 | 74 | $192,050 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 510 | $19,377 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 39 | $8,788 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 305 | $8,330 |
2022
| Return visit (30+ min) | 419 | $17,092 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 305 | $7,785 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 34 | $6,949 |
| CARDIOVASCULAR STRESS TEST | 13 | $1,830 |
| Short return visit (20+ min) | 12 | $426 |
2021
| Return visit (30+ min) | 33 | $1,698 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 19 | $451 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 342 | $46,402 |
| Return visit (30+ min) | 436 | $18,444 |
| CARDIOVASCULAR STRESS TEST | 167 | $13,574 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 209 | $11,376 |
| Injection, regadenoson, 0.1 mg | 50 | $9,326 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 274 | $6,809 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 17 | $6,788 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 58 | $6,209 |
| 1ST HOSP IP/OBS HIGH 75 | 34 | $3,561 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 12 | $2,237 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 44 | $1,556 |
| New patient visit (60+ min) | 13 | $1,422 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 596 | $76,469 |
| Return visit (30+ min) | 468 | $24,598 |
| CARDIOVASCULAR STRESS TEST | 248 | $20,244 |
| Injection, regadenoson, 0.1 mg | 73 | $14,704 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 233 | $13,809 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 98 | $10,778 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 277 | $7,377 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 15 | $6,325 |
| 1ST HOSP IP/OBS HIGH 75 | 73 | $5,779 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 134 | $4,847 |
| Tc99m sestamibi | 12 | $3,310 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 87 | $2,847 |
Drugs they prescribed that Part D paid
$726,350
Pharmacies billed $726,350 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,906 generic and 676 brand-name prescriptions · $726,350 in drug cost · 30 antibiotic prescriptions to 24 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 149 | $164,778 | $1,106 |
| Jardiance | 108 | $129,605 | $1,200 |
| Entresto | 94 | $112,742 | $1,199 |
| Ozempic | 71 | $88,066 | $1,240 |
| Xarelto | 72 | $76,931 | $1,068 |
See all 43 drugs
| Eliquis | 149 | $164,778 | $1,106 |
| Jardiance | 108 | $129,605 | $1,200 |
| Entresto | 94 | $112,742 | $1,199 |
| Ozempic | 71 | $88,066 | $1,240 |
| Xarelto | 72 | $76,931 | $1,068 |
| Repatha Sureclick | 44 | $29,985 | $681 |
| Vascepa | 20 | $15,951 | $798 |
| Brilinta | 28 | $14,797 | $528 |
| Metoprolol | 296 | $5,239 | $18 |
| Atorvastatin | 342 | $4,487 | $13 |
| Clopidogrel | 208 | $2,699 | $13 |
| Fenofibrate | 80 | $2,693 | $34 |
| Rosuvastatin | 101 | $2,254 | $22 |
| Ezetimibe | 48 | $1,994 | $42 |
| Losartan | 190 | $1,633 | $9 |
| Amiodarone | 26 | $1,559 | $60 |
| Carvedilol | 159 | $1,482 | $9 |
| Losartan-Hydrochlorothiazide | 79 | $1,339 | $17 |
| Amlodipine Besylate | 198 | $1,296 | $7 |
| Metoprolol | 124 | $1,260 | $10 |
| Potassium Chloride | 60 | $1,208 | $20 |
| Hydralazine | 80 | $1,117 | $14 |
| Ranolazine Er | 11 | $1,098 | $100 |
| Lisinopril | 115 | $905 | $8 |
| Diltiazem 24hr Er (Cd) | 21 | $839 | $40 |
| Isosorbide Mononitrate Er | 47 | $829 | $18 |
| Furosemide | 127 | $829 | $7 |
| Warfarin | 70 | $779 | $11 |
| Nitroglycerin | 27 | $630 | $23 |
| Pantoprazole | 37 | $568 | $15 |
| Midodrine | 14 | $562 | $40 |
| Fenofibrate | 16 | $506 | $32 |
| Nifedipine Er | 15 | $417 | $28 |
| Levothyroxine | 11 | $400 | $36 |
| Lisinopril-Hydrochlorothiazide | 23 | $365 | $16 |
| Spironolactone | 56 | $352 | $6 |
| Simvastatin | 24 | $334 | $14 |
| Benazepril | 18 | $178 | $10 |
| Famotidine | 13 | $150 | $12 |
| Hydrochlorothiazide | 50 | $137 | $3 |
| Allopurinol | 13 | $137 | $11 |
| Atenolol | 18 | $119 | $7 |
| Metformin | 12 | $105 | $9 |
Year by year
| 2024 | 3,582 | 924 | None | 19% | $726,350 |
| 2023 | 2,747 | 807 | None | None | $543,627 |
| 2022 | 2,025 | 617 | None | 15% | $276,599 |
| 2021 | 938 | 316 | 0% (0) | 17% | $115,031 |
| 2020 | 2,526 | 699 | None | 14% | $219,806 |
| 2019 | 9,296 | 1,098 | None | 16% | $888,146 |
| 2018 | 9,963 | 1,103 | 0% (20) | None | $820,505 |
| 2017 | 9,606 | 1,034 | 0% (38) | None | $630,450 |
| 2016 | 10,426 | 987 | 0% (19) | 18% | $570,513 |
| 2015 | 10,374 | 951 | 0% (37) | 18% | $503,658 |
| 2014 | 10,587 | 926 | 0% (40) | None | $491,236 |
| 2013 | 9,916 | 845 | 1% (52) | None | $440,016 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 38 drugs
| Eliquis | 138 | $147,559 | $1,069 |
| Entresto | 66 | $92,484 | $1,401 |
| Jardiance | 55 | $74,144 | $1,348 |
| Xarelto | 49 | $72,206 | $1,474 |
| Repatha Sureclick | 22 | $17,004 | $773 |
| Brilinta | 26 | $15,960 | $614 |
| Metoprolol | 255 | $7,558 | $30 |
| Atorvastatin | 273 | $5,691 | $21 |
| Clopidogrel | 140 | $3,260 | $23 |
| Ranolazine Er | 11 | $2,650 | $241 |
| Losartan | 145 | $2,626 | $18 |
| Fenofibrate | 46 | $2,222 | $48 |
| Carvedilol | 114 | $2,122 | $19 |
| Amlodipine Besylate | 158 | $2,025 | $13 |
| Losartan-Hydrochlorothiazide | 58 | $1,875 | $32 |
| Rosuvastatin | 59 | $1,759 | $30 |
| Lisinopril | 99 | $1,453 | $15 |
| Ezetimibe | 24 | $1,395 | $58 |
| Amiodarone | 32 | $1,347 | $42 |
| Diltiazem 24hr Er (Cd) | 13 | $1,241 | $95 |
| Potassium Chloride | 45 | $1,187 | $26 |
| Isosorbide Mononitrate Er | 42 | $1,124 | $27 |
| Hydralazine | 57 | $1,089 | $19 |
| Benazepril | 37 | $1,071 | $29 |
| Furosemide | 138 | $1,035 | $8 |
| Metoprolol | 89 | $995 | $11 |
| Warfarin | 53 | $820 | $15 |
| Nifedipine Er | 13 | $811 | $62 |
| Hydrochlorothiazide | 56 | $703 | $13 |
| Nitroglycerin | 21 | $590 | $28 |
| Lisinopril-Hydrochlorothiazide | 24 | $573 | $24 |
| Fenofibrate | 15 | $517 | $34 |
| Spironolactone | 32 | $459 | $14 |
| Pantoprazole | 22 | $448 | $20 |
| Omeprazole | 11 | $348 | $32 |
| Simvastatin | 24 | $251 | $10 |
| Tamsulosin | 12 | $193 | $16 |
| Gabapentin | 11 | $159 | $14 |
2022: 33 drugs
| Eliquis | 102 | $88,078 | $864 |
| Entresto | 36 | $46,574 | $1,294 |
| Xarelto | 24 | $29,748 | $1,240 |
| Brilinta | 24 | $18,675 | $778 |
| Repatha Sureclick | 14 | $15,363 | $1,097 |
| Metoprolol | 206 | $4,366 | $21 |
| Atorvastatin | 237 | $4,317 | $18 |
| Fenofibrate | 30 | $2,330 | $78 |
| Clopidogrel | 107 | $1,989 | $19 |
| Amiodarone | 25 | $1,847 | $74 |
| Losartan | 95 | $1,582 | $17 |
| Carvedilol | 100 | $1,310 | $13 |
| Fenofibrate | 27 | $1,292 | $48 |
| Amlodipine Besylate | 134 | $1,279 | $10 |
| Isosorbide Mononitrate Er | 38 | $1,188 | $31 |
| Ezetimibe | 21 | $1,115 | $53 |
| Diltiazem 24hr Er (Cd) | 15 | $1,104 | $74 |
| Rosuvastatin | 20 | $893 | $45 |
| Potassium Chloride | 28 | $886 | $32 |
| Metoprolol | 83 | $783 | $9 |
| Furosemide | 109 | $759 | $7 |
| Hydralazine | 44 | $665 | $15 |
| Lisinopril | 72 | $585 | $8 |
| Losartan-Hydrochlorothiazide | 30 | $512 | $17 |
| Benazepril | 21 | $495 | $24 |
| Nitroglycerin | 15 | $474 | $32 |
| Pantoprazole | 26 | $461 | $18 |
| Warfarin | 18 | $263 | $15 |
| Lisinopril-Hydrochlorothiazide | 13 | $146 | $11 |
| Spironolactone | 21 | $124 | $6 |
| Famotidine | 16 | $117 | $7 |
| Hydrochlorothiazide | 25 | $111 | $4 |
| Simvastatin | 14 | $101 | $7 |
2021: 23 drugs
| Eliquis | 49 | $35,094 | $716 |
| Xarelto | 22 | $26,188 | $1,190 |
| Brilinta | 18 | $15,848 | $880 |
| Repatha Sureclick | 12 | $5,557 | $463 |
| Metoprolol | 76 | $2,059 | $27 |
| Atorvastatin | 97 | $1,481 | $15 |
| Potassium Chloride | 19 | $807 | $42 |
| Nitroglycerin | 20 | $799 | $40 |
| Diltiazem 24hr Er (Cd) | 17 | $715 | $42 |
| Fenofibrate | 11 | $654 | $59 |
| Clopidogrel | 61 | $642 | $11 |
| Losartan | 51 | $540 | $11 |
| Pantoprazole | 22 | $530 | $24 |
| Carvedilol | 48 | $529 | $11 |
| Isosorbide Mononitrate Er | 29 | $411 | $14 |
| Amlodipine Besylate | 54 | $320 | $6 |
| Metoprolol | 37 | $300 | $8 |
| Lisinopril | 44 | $296 | $7 |
| Benazepril | 12 | $261 | $22 |
| Furosemide | 32 | $239 | $7 |
| Hydralazine | 12 | $206 | $17 |
| Warfarin | 17 | $188 | $11 |
| Hydrochlorothiazide | 13 | $98 | $8 |
2020: 37 drugs
| Eliquis | 77 | $65,506 | $851 |
| Xarelto | 52 | $45,506 | $875 |
| Brilinta | 21 | $17,127 | $816 |
| Vascepa | 17 | $7,321 | $431 |
| Metoprolol | 255 | $5,877 | $23 |
| Ranolazine Er | 31 | $5,343 | $172 |
| Atorvastatin | 271 | $4,183 | $15 |
| Clopidogrel | 194 | $2,407 | $12 |
| Potassium Chloride | 53 | $2,361 | $45 |
| Nitroglycerin | 37 | $1,724 | $47 |
| Rosuvastatin | 29 | $1,652 | $57 |
| Ezetimibe | 26 | $1,364 | $52 |
| Amiodarone | 30 | $1,349 | $45 |
| Isosorbide Mononitrate Er | 83 | $1,329 | $16 |
| Carvedilol | 121 | $1,196 | $10 |
| Losartan | 101 | $1,073 | $11 |
| Furosemide | 123 | $1,022 | $8 |
| Fenofibrate | 21 | $976 | $46 |
| Losartan-Hydrochlorothiazide | 27 | $929 | $34 |
| Digoxin | 12 | $888 | $74 |
| Amlodipine Besylate | 140 | $864 | $6 |
| Warfarin | 56 | $820 | $15 |
| Lisinopril | 118 | $740 | $6 |
| Pantoprazole | 37 | $605 | $16 |
| Diltiazem 24hr Er (Cd) | 28 | $585 | $21 |
| Simvastatin | 61 | $583 | $10 |
| Benazepril | 30 | $577 | $19 |
| Nifedipine Er | 17 | $573 | $34 |
| Metoprolol | 65 | $551 | $8 |
| Hydralazine | 23 | $505 | $22 |
| Hydrochlorothiazide | 60 | $395 | $7 |
| Levothyroxine | 16 | $363 | $23 |
| Pravastatin | 12 | $307 | $26 |
| Spironolactone | 31 | $298 | $10 |
| Omeprazole | 17 | $275 | $16 |
| Atenolol | 24 | $192 | $8 |
| Clonidine | 11 | $126 | $11 |
2019: 73 drugs
| Eliquis | 308 | $225,066 | $731 |
| Xarelto | 179 | $149,277 | $834 |
| Brilinta | 131 | $88,359 | $674 |
| Entresto | 89 | $73,335 | $824 |
| Metoprolol | 905 | $25,790 | $28 |
| Ranexa | 20 | $21,224 | $1,061 |
| Ranolazine Er | 44 | $19,318 | $439 |
| Atorvastatin | 981 | $18,320 | $19 |
| Vascepa | 44 | $17,370 | $395 |
| Repatha Sureclick | 21 | $15,650 | $745 |
| Januvia | 12 | $12,119 | $1,010 |
| Jardiance | 14 | $11,238 | $803 |
| Dexilant | 19 | $9,804 | $516 |
| Pradaxa | 22 | $9,793 | $445 |
| Clopidogrel | 576 | $9,038 | $16 |
| Potassium Chloride | 184 | $7,188 | $39 |
| Rosuvastatin | 112 | $6,144 | $55 |
| Amiodarone | 148 | $5,414 | $37 |
| Isosorbide Mononitrate Er | 252 | $5,308 | $21 |
| Losartan | 373 | $4,218 | $11 |
| Carvedilol | 404 | $4,152 | $10 |
| Furosemide | 469 | $3,749 | $8 |
| Nitroglycerin | 86 | $3,519 | $41 |
| Lisinopril | 432 | $3,463 | $8 |
| Bystolic | 12 | $3,431 | $286 |
| Ezetimibe | 51 | $3,377 | $66 |
| Amlodipine Besylate | 404 | $3,049 | $8 |
| Fenofibrate | 62 | $2,913 | $47 |
| Warfarin | 254 | $2,807 | $11 |
| Metoprolol | 351 | $2,667 | $8 |
| Fenofibrate | 45 | $2,496 | $55 |
| Fenofibrate | 34 | $2,207 | $65 |
| Simvastatin | 244 | $2,164 | $9 |
| Hydralazine | 112 | $1,832 | $16 |
| Spironolactone | 137 | $1,752 | $13 |
| Nifedipine Er | 76 | $1,740 | $23 |
| Diltiazem 24hr Er (Cd) | 47 | $1,677 | $36 |
| Propafenone Hcl Er | 11 | $1,554 | $141 |
| Losartan-Hydrochlorothiazide | 107 | $1,491 | $14 |
| Pravastatin | 67 | $1,479 | $22 |
| Pantoprazole | 82 | $1,422 | $17 |
| Levothyroxine | 56 | $1,386 | $25 |
| Proair Hfa | 15 | $1,316 | $88 |
| Bumetanide | 15 | $1,302 | $87 |
| Cilostazol | 27 | $1,170 | $43 |
| Olmesartan Medoxomil | 43 | $1,166 | $27 |
| Omeprazole | 63 | $1,092 | $17 |
| Benazepril | 91 | $1,063 | $12 |
| Digoxin | 17 | $1,006 | $59 |
| Cartia Xt | 37 | $1,005 | $27 |
| Allopurinol | 43 | $972 | $23 |
| Diltiazem | 25 | $921 | $37 |
| Hydrochlorothiazide | 132 | $921 | $7 |
| Digox | 18 | $914 | $51 |
| Amlodipine Besylate-Benazepril | 15 | $861 | $57 |
| Diltiazem 24hr Er | 14 | $775 | $55 |
| Valsartan | 13 | $775 | $60 |
| Dilt-Xr | 11 | $725 | $66 |
| Flecainide Acetate | 11 | $711 | $65 |
| Verapamil Er | 30 | $708 | $24 |
| Atenolol | 70 | $678 | $10 |
| Triamterene-Hydrochlorothiazid | 27 | $505 | $19 |
| Pentoxifylline | 11 | $500 | $45 |
| Captopril | 11 | $494 | $45 |
| Tamsulosin | 16 | $433 | $27 |
| Enalapril Maleate | 15 | $415 | $28 |
| Gemfibrozil | 14 | $403 | $29 |
| Clonidine | 42 | $398 | $9 |
| Lovastatin | 21 | $223 | $11 |
| Famotidine | 20 | $156 | $8 |
| Cephalexin | 11 | $145 | $13 |
| Metformin | 16 | $136 | $9 |
| Azithromycin | 15 | $121 | $8 |
2018: 79 drugs
| Xarelto | 222 | $167,596 | $755 |
| Eliquis | 183 | $130,483 | $713 |
| Brilinta | 152 | $87,098 | $573 |
| Ranexa | 72 | $60,710 | $843 |
| Entresto | 55 | $36,850 | $670 |
| Metoprolol | 808 | $28,025 | $35 |
| Vascepa | 54 | $21,685 | $402 |
| Atorvastatin | 1,009 | $18,961 | $19 |
| Pradaxa | 30 | $18,783 | $626 |
| Januvia | 16 | $11,586 | $724 |
| Potassium Chloride | 230 | $8,771 | $38 |
| Ezetimibe | 63 | $8,647 | $137 |
| Amiodarone | 181 | $8,321 | $46 |
| Clopidogrel | 563 | $7,829 | $14 |
| Rosuvastatin | 145 | $6,442 | $44 |
| Isosorbide Mononitrate Er | 254 | $6,097 | $24 |
| Nitroglycerin | 136 | $5,714 | $42 |
| Fenofibrate | 56 | $5,360 | $96 |
| Spiriva | 13 | $5,299 | $408 |
| Prasugrel | 16 | $5,275 | $330 |
| Bystolic | 11 | $4,853 | $441 |
| Warfarin | 378 | $4,298 | $11 |
| Carvedilol | 501 | $4,261 | $9 |
| Furosemide | 552 | $3,952 | $7 |
| Fenofibrate | 65 | $3,725 | $57 |
| Fenofibrate | 49 | $3,656 | $75 |
| Metoprolol | 460 | $3,510 | $8 |
| Losartan | 341 | $3,287 | $10 |
| Amlodipine Besylate | 384 | $3,140 | $8 |
| Lisinopril | 445 | $3,048 | $7 |
| Flecainide Acetate | 17 | $2,407 | $142 |
| Simvastatin | 265 | $2,372 | $9 |
| Pravastatin | 87 | $2,110 | $24 |
| Levothyroxine | 86 | $2,102 | $24 |
| Cartia Xt | 75 | $1,888 | $25 |
| Cilostazol | 48 | $1,870 | $39 |
| Hydralazine | 106 | $1,834 | $17 |
| Spironolactone | 164 | $1,762 | $11 |
| Fenofibric Acid | 11 | $1,668 | $152 |
| Valsartan | 32 | $1,629 | $51 |
| Pantoprazole | 106 | $1,588 | $15 |
| Olmesartan Medoxomil | 14 | $1,562 | $112 |
| Isosorbide Dinitrate | 16 | $1,477 | $92 |
| Digox | 20 | $1,427 | $71 |
| Proair Hfa | 14 | $1,387 | $99 |
| Midodrine | 21 | $1,368 | $65 |
| Amlodipine Besylate-Benazepril | 17 | $1,337 | $79 |
| Verapamil Er | 42 | $1,327 | $32 |
| Omeprazole | 70 | $1,306 | $19 |
| Pentoxifylline | 39 | $1,296 | $33 |
| Metolazone | 18 | $1,259 | $70 |
| Nifedipine Er | 33 | $1,243 | $38 |
| Benazepril | 131 | $1,243 | $9 |
| Propranolol | 21 | $1,201 | $57 |
| Hydrochlorothiazide | 113 | $1,039 | $9 |
| Digoxin | 16 | $1,023 | $64 |
| Losartan-Hydrochlorothiazide | 70 | $995 | $14 |
| Diltiazem | 28 | $966 | $34 |
| Diltiazem 24hr Er | 17 | $920 | $54 |
| Diltiazem 24hr Er (Cd) | 25 | $909 | $36 |
| Valsartan-Hydrochlorothiazide | 17 | $801 | $47 |
| Enalapril Maleate | 22 | $749 | $34 |
| Atenolol | 72 | $745 | $10 |
| Allopurinol | 38 | $688 | $18 |
| Triamterene-Hydrochlorothiazid | 23 | $477 | $21 |
| Tamsulosin | 17 | $384 | $23 |
| Meclizine | 16 | $355 | $22 |
| Ramipril | 26 | $282 | $11 |
| Azithromycin | 32 | $250 | $8 |
| Clonidine | 18 | $236 | $13 |
| Verapamil | 11 | $200 | $18 |
| Gabapentin | 24 | $165 | $7 |
| Famotidine | 12 | $152 | $13 |
| Cephalexin | 16 | $126 | $8 |
| Jantoven | 13 | $126 | $10 |
| Lovastatin | 11 | $98 | $9 |
| Metformin | 14 | $98 | $7 |
| Donepezil | 15 | $90 | $6 |
| Alprazolam | 12 | $84 | $7 |
2017: 81 drugs
| Xarelto | 192 | $127,279 | $663 |
| Eliquis | 106 | $62,199 | $587 |
| Ranexa | 61 | $43,433 | $712 |
| Brilinta | 81 | $40,911 | $505 |
| Metoprolol | 687 | $24,842 | $36 |
| Pradaxa | 31 | $17,390 | $561 |
| Atorvastatin | 854 | $16,449 | $19 |
| Vascepa | 42 | $15,141 | $360 |
| Effient | 17 | $14,661 | $862 |
| Zetia | 34 | $14,183 | $417 |
| Ezetimibe | 34 | $11,903 | $350 |
| Januvia | 20 | $9,413 | $471 |
| Amiodarone | 206 | $9,382 | $46 |
| Potassium Chloride | 204 | $7,373 | $36 |
| Entresto | 12 | $6,913 | $576 |
| Clopidogrel | 551 | $6,896 | $13 |
| Isosorbide Mononitrate Er | 335 | $6,784 | $20 |
| Rosuvastatin | 114 | $6,540 | $57 |
| Nitroglycerin | 113 | $5,892 | $52 |
| Dofetilide | 11 | $5,798 | $527 |
| Bystolic | 12 | $5,205 | $434 |
| Warfarin | 479 | $4,704 | $10 |
| Fenofibrate | 58 | $4,584 | $79 |
| Carvedilol | 518 | $3,916 | $8 |
| Niacin Er | 21 | $3,730 | $178 |
| Losartan | 328 | $3,669 | $11 |
| Fenofibrate | 57 | $3,567 | $63 |
| Furosemide | 490 | $3,425 | $7 |
| Fenofibric Acid | 20 | $3,160 | $158 |
| Metoprolol | 427 | $3,157 | $7 |
| Lisinopril | 382 | $3,092 | $8 |
| Fenofibrate | 38 | $3,056 | $80 |
| Amlodipine Besylate | 376 | $2,986 | $8 |
| Pravastatin | 84 | $2,612 | $31 |
| Nifedipine Er | 44 | $2,482 | $56 |
| Simvastatin | 279 | $2,368 | $8 |
| Omeprazole | 80 | $2,289 | $29 |
| Coumadin | 28 | $2,180 | $78 |
| Digoxin | 42 | $2,132 | $51 |
| Diltiazem 24hr Er | 55 | $1,929 | $35 |
| Levothyroxine | 79 | $1,802 | $23 |
| Flecainide Acetate | 11 | $1,798 | $163 |
| Cartia Xt | 58 | $1,761 | $30 |
| Isosorbide Dinitrate | 18 | $1,760 | $98 |
| Valsartan | 36 | $1,662 | $46 |
| Metolazone | 19 | $1,546 | $81 |
| Diltiazem | 45 | $1,458 | $32 |
| Cilostazol | 50 | $1,375 | $28 |
| Digox | 17 | $1,348 | $79 |
| Verapamil Er | 28 | $1,289 | $46 |
| Pantoprazole | 90 | $1,258 | $14 |
| Hydralazine | 81 | $1,253 | $15 |
| Spironolactone | 118 | $1,248 | $11 |
| Benazepril | 132 | $1,190 | $9 |
| Valsartan-Hydrochlorothiazide | 29 | $1,180 | $41 |
| Hydrochlorothiazide | 134 | $1,106 | $8 |
| Pentoxifylline | 35 | $1,094 | $31 |
| Proair Hfa | 13 | $908 | $70 |
| Amlodipine Besylate-Benazepril | 15 | $876 | $58 |
| Propranolol | 24 | $859 | $36 |
| Allopurinol | 38 | $854 | $22 |
| Klor-Con Sprinkle | 22 | $839 | $38 |
| Enalapril Maleate | 31 | $833 | $27 |
| Atenolol | 87 | $774 | $9 |
| Losartan-Hydrochlorothiazide | 57 | $626 | $11 |
| Dilt-Xr | 13 | $571 | $44 |
| Ramipril | 24 | $430 | $18 |
| Triamterene-Hydrochlorothiazid | 20 | $374 | $19 |
| Finasteride | 11 | $364 | $33 |
| Tamsulosin | 15 | $341 | $23 |
| Lovastatin | 16 | $313 | $20 |
| Meclizine | 18 | $279 | $15 |
| Azithromycin | 27 | $243 | $9 |
| Cephalexin | 21 | $234 | $11 |
| Tramadol | 18 | $228 | $13 |
| Jantoven | 29 | $195 | $7 |
| Metformin | 26 | $194 | $7 |
| Ranitidine | 16 | $180 | $11 |
| Verapamil | 13 | $149 | $11 |
| Alprazolam | 23 | $138 | $6 |
| Gabapentin | 18 | $109 | $6 |
2016: 88 drugs
| Xarelto | 177 | $100,698 | $569 |
| Crestor | 92 | $38,781 | $422 |
| Ranexa | 66 | $35,921 | $544 |
| Eliquis | 88 | $35,036 | $398 |
| Zetia | 59 | $24,872 | $422 |
| Metoprolol | 723 | $24,160 | $33 |
| Pradaxa | 56 | $23,518 | $420 |
| Brilinta | 54 | $22,628 | $419 |
| Atorvastatin | 843 | $16,867 | $20 |
| Effient | 27 | $14,102 | $522 |
| Januvia | 30 | $13,735 | $458 |
| Vascepa | 29 | $9,004 | $310 |
| Clopidogrel | 671 | $8,810 | $13 |
| Potassium Chloride | 249 | $8,144 | $33 |
| Fenofibrate | 51 | $7,360 | $144 |
| Multaq | 13 | $7,264 | $559 |
| Isosorbide Mononitrate Er | 354 | $6,157 | $17 |
| Benicar | 22 | $6,148 | $279 |
| Niacin Er | 37 | $6,009 | $162 |
| Carvedilol | 600 | $5,169 | $9 |
| Amiodarone | 238 | $5,059 | $21 |
| Nitrostat | 94 | $4,857 | $52 |
| Fenofibrate | 68 | $4,843 | $71 |
| Warfarin | 517 | $4,726 | $9 |
| Fenofibric Acid | 23 | $4,300 | $187 |
| Bystolic | 14 | $3,871 | $277 |
| Omega-3 Acid Ethyl Esters | 15 | $3,824 | $255 |
| Metoprolol | 517 | $3,594 | $7 |
| Lisinopril | 445 | $3,391 | $8 |
| Losartan | 346 | $3,326 | $10 |
| Furosemide | 528 | $3,301 | $6 |
| Amlodipine Besylate | 412 | $3,221 | $8 |
| Fenofibrate | 17 | $3,126 | $184 |
| Rosuvastatin | 30 | $3,055 | $102 |
| Pravastatin | 88 | $3,013 | $34 |
| Simvastatin | 358 | $2,867 | $8 |
| Diltiazem 24hr Er | 83 | $2,379 | $29 |
| Coumadin | 26 | $2,118 | $81 |
| Levothyroxine | 83 | $1,904 | $23 |
| Nitroglycerin | 32 | $1,871 | $58 |
| Valsartan | 48 | $1,827 | $38 |
| Digox | 29 | $1,766 | $61 |
| Omeprazole | 87 | $1,709 | $20 |
| Digoxin | 57 | $1,679 | $29 |
| Cilostazol | 61 | $1,673 | $27 |
| Hydrochlorothiazide | 178 | $1,562 | $9 |
| Midodrine | 20 | $1,466 | $73 |
| Pantoprazole | 98 | $1,392 | $14 |
| Isosorbide Dinitrate | 16 | $1,358 | $85 |
| Benazepril | 155 | $1,289 | $8 |
| Hydralazine | 80 | $1,278 | $16 |
| Nifedipine Er | 17 | $1,271 | $75 |
| Metolazone | 20 | $1,211 | $61 |
| Atenolol | 131 | $1,104 | $8 |
| Enalapril Maleate | 28 | $1,087 | $39 |
| Spironolactone | 88 | $1,072 | $12 |
| Amlodipine Besylate-Benazepril | 20 | $983 | $49 |
| Losartan-Hydrochlorothiazide | 64 | $975 | $15 |
| Verapamil Er | 35 | $973 | $28 |
| Diltiazem | 58 | $960 | $17 |
| Proair Hfa | 14 | $786 | $56 |
| Cartia Xt | 31 | $784 | $25 |
| Allopurinol | 45 | $776 | $17 |
| Tamsulosin | 42 | $765 | $18 |
| Taztia Xt | 12 | $750 | $62 |
| Pentoxifylline | 30 | $736 | $25 |
| Propranolol | 20 | $673 | $34 |
| Dilt-Xr | 20 | $605 | $30 |
| Diltiazem 24hr Cd | 16 | $599 | $37 |
| Propafenone | 24 | $554 | $23 |
| Valsartan-Hydrochlorothiazide | 13 | $525 | $40 |
| Nifedical Xl | 11 | $502 | $46 |
| Klor-Con 8 | 13 | $471 | $36 |
| Cephalexin | 34 | $468 | $14 |
| Ramipril | 32 | $452 | $14 |
| Bupropion Hcl Sr | 12 | $418 | $35 |
| Ranitidine | 26 | $394 | $15 |
| Triamterene-Hydrochlorothiazid | 18 | $318 | $18 |
| Klor-Con 10 | 16 | $267 | $17 |
| Metformin | 33 | $210 | $6 |
| Meclizine | 13 | $208 | $16 |
| Jantoven | 23 | $190 | $8 |
| Alprazolam | 25 | $183 | $7 |
| Lovastatin | 12 | $174 | $15 |
| Verapamil | 15 | $118 | $8 |
| Azithromycin | 14 | $83 | $6 |
| Isosorbide Mononitrate | 16 | $70 | $4 |
| Quinapril | 12 | $68 | $6 |
2015: 99 drugs
| Xarelto | 111 | $49,792 | $449 |
| Crestor | 127 | $40,965 | $323 |
| Ranexa | 68 | $28,831 | $424 |
| Metoprolol | 735 | $25,816 | $35 |
| Zetia | 65 | $21,331 | $328 |
| Pradaxa | 47 | $17,889 | $381 |
| Januvia | 40 | $17,407 | $435 |
| Eliquis | 34 | $16,014 | $471 |
| Atorvastatin | 753 | $15,773 | $21 |
| Brilinta | 44 | $14,927 | $339 |
| Clopidogrel | 639 | $12,303 | $19 |
| Multaq | 21 | $10,272 | $489 |
| Niacin Er | 46 | $8,849 | $192 |
| Effient | 25 | $8,769 | $351 |
| Fenofibrate | 55 | $8,710 | $158 |
| Isosorbide Mononitrate Er | 372 | $7,515 | $20 |
| Potassium Chloride | 229 | $7,188 | $31 |
| Diovan | 27 | $7,002 | $259 |
| Vascepa | 28 | $6,715 | $240 |
| Amiodarone | 247 | $6,109 | $25 |
| Dexilant | 11 | $5,958 | $542 |
| Warfarin | 617 | $5,935 | $10 |
| Nexium | 23 | $5,709 | $248 |
| Benicar | 25 | $5,685 | $227 |
| Fenofibric Acid | 27 | $5,522 | $205 |
| Fenofibrate | 84 | $5,352 | $64 |
| Carvedilol | 566 | $4,763 | $8 |
| Tikosyn | 13 | $4,437 | $341 |
| Fenofibrate | 13 | $4,245 | $327 |
| Simvastatin | 464 | $3,552 | $8 |
| Nitrostat | 112 | $3,454 | $31 |
| Omega-3 Acid Ethyl Esters | 12 | $3,434 | $286 |
| Amlodipine Besylate | 425 | $3,071 | $7 |
| Lisinopril | 415 | $2,967 | $7 |
| Losartan | 287 | $2,775 | $10 |
| Furosemide | 474 | $2,760 | $6 |
| Metoprolol | 439 | $2,710 | $6 |
| Pravastatin | 83 | $2,651 | $32 |
| Levothyroxine | 124 | $2,601 | $21 |
| Bystolic | 11 | $2,492 | $227 |
| Coumadin | 26 | $2,032 | $78 |
| Valsartan | 28 | $1,908 | $68 |
| Nifedipine Er | 28 | $1,908 | $68 |
| Digox | 39 | $1,840 | $47 |
| Pantoprazole | 109 | $1,836 | $17 |
| Digoxin | 43 | $1,825 | $42 |
| Hydrochlorothiazide | 201 | $1,748 | $9 |
| Benazepril | 144 | $1,677 | $12 |
| Omeprazole | 109 | $1,534 | $14 |
| Hydralazine | 84 | $1,449 | $17 |
| Isosorbide Dinitrate | 23 | $1,382 | $60 |
| Diltiazem 24hr Er | 36 | $1,375 | $38 |
| Cilostazol | 47 | $1,336 | $28 |
| Cartia Xt | 54 | $1,301 | $24 |
| Flecainide Acetate | 15 | $1,288 | $86 |
| Atenolol | 142 | $1,268 | $9 |
| Captopril | 11 | $1,241 | $113 |
| Bumetanide | 17 | $1,216 | $72 |
| Metolazone | 32 | $1,209 | $38 |
| Valsartan-Hydrochlorothiazide | 15 | $1,142 | $76 |
| Enalapril Maleate | 26 | $1,109 | $43 |
| Diltiazem 24hr Cd | 45 | $999 | $22 |
| Allopurinol | 48 | $988 | $21 |
| Dilt-Xr | 24 | $967 | $40 |
| Verapamil Er | 53 | $888 | $17 |
| Tamsulosin | 16 | $724 | $45 |
| Losartan-Hydrochlorothiazide | 60 | $711 | $12 |
| Nifedical Xl | 11 | $699 | $64 |
| Propranolol | 29 | $675 | $23 |
| Spironolactone | 67 | $654 | $10 |
| Proair Hfa | 12 | $626 | $52 |
| Pentoxifylline | 36 | $560 | $16 |
| Bupropion Hcl Sr | 11 | $501 | $46 |
| Midodrine | 13 | $463 | $36 |
| Amlodipine Besylate-Benazepril | 14 | $435 | $31 |
| Diltiazem | 35 | $430 | $12 |
| Klor-Con 8 | 12 | $405 | $34 |
| Triamterene-Hydrochlorothiazid | 15 | $393 | $26 |
| Hydrocodone-Acetaminophen | 12 | $359 | $30 |
| Cephalexin | 23 | $323 | $14 |
| Metformin | 54 | $305 | $6 |
| Ramipril | 18 | $288 | $16 |
| Tramadol | 12 | $252 | $21 |
| Finasteride | 17 | $239 | $14 |
| Meclizine | 14 | $234 | $17 |
| Ranitidine | 15 | $231 | $15 |
| Famotidine | 17 | $188 | $11 |
| Alprazolam | 31 | $177 | $6 |
| Dicyclomine | 11 | $174 | $16 |
| Isosorbide Mononitrate | 27 | $165 | $6 |
| Lisinopril-Hydrochlorothiazide | 14 | $144 | $10 |
| Gabapentin | 14 | $143 | $10 |
| Klor-Con 10 | 13 | $142 | $11 |
| Sertraline | 12 | $139 | $12 |
| Verapamil | 19 | $138 | $7 |
| Acetaminophen-Codeine | 11 | $106 | $10 |
| Quinapril | 15 | $102 | $7 |
| Azithromycin | 13 | $98 | $8 |
| Primidone | 13 | $82 | $6 |
2014: 97 drugs
| Crestor | 159 | $44,479 | $280 |
| Ranexa | 80 | $32,036 | $400 |
| Metoprolol | 762 | $28,091 | $37 |
| Januvia | 55 | $24,395 | $444 |
| Xarelto | 51 | $21,170 | $415 |
| Pradaxa | 46 | $20,712 | $450 |
| Diovan | 63 | $19,751 | $314 |
| Atorvastatin | 653 | $18,732 | $29 |
| Clopidogrel | 665 | $14,138 | $21 |
| Zetia | 56 | $13,213 | $236 |
| Fenofibrate | 61 | $12,163 | $199 |
| Niacin Er | 47 | $11,490 | $244 |
| Isosorbide Mononitrate Er | 437 | $8,568 | $20 |
| Effient | 27 | $8,550 | $317 |
| Nexium | 28 | $8,123 | $290 |
| Fenofibrate | 93 | $7,999 | $86 |
| Inderal La | 12 | $6,569 | $547 |
| Carvedilol | 599 | $6,470 | $11 |
| Benicar | 29 | $6,453 | $223 |
| Advair Diskus | 15 | $5,877 | $392 |
| Warfarin | 627 | $5,808 | $9 |
| Vytorin | 18 | $5,629 | $313 |
| Simvastatin | 559 | $5,349 | $10 |
| Potassium Chloride | 154 | $5,306 | $34 |
| Lovaza | 17 | $4,776 | $281 |
| Multaq | 11 | $4,622 | $420 |
| Losartan | 312 | $4,602 | $15 |
| Digox | 63 | $4,005 | $64 |
| Nifedipine Er | 49 | $3,889 | $79 |
| Amlodipine Besylate | 436 | $3,819 | $9 |
| Amiodarone | 159 | $3,747 | $24 |
| Fenofibric Acid | 12 | $3,300 | $275 |
| Telmisartan | 14 | $3,148 | $225 |
| Lisinopril | 377 | $2,897 | $8 |
| Metoprolol | 375 | $2,882 | $8 |
| Nitrostat | 99 | $2,874 | $29 |
| Levothyroxine | 177 | $2,748 | $16 |
| Niaspan | 12 | $2,697 | $225 |
| Captopril | 46 | $2,580 | $56 |
| Pravastatin | 76 | $2,501 | $33 |
| Cilostazol | 57 | $2,452 | $43 |
| Furosemide | 420 | $2,273 | $5 |
| Bystolic | 17 | $2,166 | $127 |
| Omeprazole | 160 | $1,956 | $12 |
| Benazepril | 144 | $1,809 | $13 |
| Diltiazem 24hr Er | 61 | $1,726 | $28 |
| Pantoprazole | 109 | $1,705 | $16 |
| Hydrochlorothiazide | 210 | $1,700 | $8 |
| Atenolol | 171 | $1,560 | $9 |
| Valsartan-Hydrochlorothiazide | 19 | $1,494 | $79 |
| Hydralazine | 79 | $1,475 | $19 |
| Coumadin | 23 | $1,361 | $59 |
| Pioglitazone | 12 | $1,322 | $110 |
| Digoxin | 32 | $1,286 | $40 |
| Diltiazem 24hr Cd | 59 | $1,273 | $22 |
| Losartan-Hydrochlorothiazide | 79 | $1,197 | $15 |
| Proair Hfa | 20 | $1,081 | $54 |
| Verapamil Er | 53 | $997 | $19 |
| Diltiazem Er | 21 | $951 | $45 |
| Spironolactone | 101 | $946 | $9 |
| Pentoxifylline | 33 | $819 | $25 |
| Cartia Xt | 24 | $775 | $32 |
| Klor-Con 8 | 29 | $772 | $27 |
| Metolazone | 21 | $760 | $36 |
| Allopurinol | 53 | $707 | $13 |
| Enalapril Maleate | 43 | $694 | $16 |
| Klor-Con 10 | 25 | $661 | $26 |
| Midodrine | 14 | $659 | $47 |
| Mexiletine | 15 | $631 | $42 |
| Doxazosin Mesylate | 21 | $602 | $29 |
| Isosorbide Dinitrate | 11 | $565 | $51 |
| Ramipril | 29 | $506 | $17 |
| Bumetanide | 12 | $503 | $42 |
| Labetalol | 13 | $502 | $39 |
| Hydrocodone-Acetaminophen | 18 | $456 | $25 |
| Diltiazem | 33 | $433 | $13 |
| Donepezil | 15 | $428 | $29 |
| Irbesartan-Hydrochlorothiazide | 11 | $424 | $39 |
| Bupropion Hcl Sr | 11 | $407 | $37 |
| Quinapril | 26 | $373 | $14 |
| Triamterene-Hydrochlorothiazid | 15 | $326 | $22 |
| Ranitidine | 20 | $289 | $14 |
| Metformin | 33 | $284 | $9 |
| Azithromycin | 33 | $281 | $9 |
| Cephalexin | 19 | $279 | $15 |
| Isosorbide Mononitrate | 38 | $273 | $7 |
| Famotidine | 23 | $266 | $12 |
| Finasteride | 24 | $259 | $11 |
| Alprazolam | 41 | $259 | $6 |
| Clonidine | 21 | $233 | $11 |
| Propranolol | 24 | $184 | $8 |
| Tamsulosin | 12 | $169 | $14 |
| Verapamil | 20 | $148 | $7 |
| Zolpidem | 12 | $129 | $11 |
| Temazepam | 24 | $116 | $5 |
| Tramadol | 12 | $109 | $9 |
| Trazodone | 11 | $19 | $2 |
2013: 96 drugs
| Crestor | 173 | $35,752 | $207 |
| Clopidogrel | 600 | $28,662 | $48 |
| Metoprolol | 703 | $26,312 | $37 |
| Atorvastatin | 512 | $19,456 | $38 |
| Pradaxa | 62 | $18,277 | $295 |
| Diovan | 81 | $17,404 | $215 |
| Xarelto | 45 | $16,400 | $364 |
| Januvia | 49 | $16,138 | $329 |
| Ranexa | 48 | $15,076 | $314 |
| Niaspan | 49 | $14,233 | $290 |
| Zetia | 45 | $8,509 | $189 |
| Fenofibrate | 138 | $8,445 | $61 |
| Fenofibrate | 38 | $8,145 | $214 |
| Lovaza | 27 | $7,042 | $261 |
| Isosorbide Mononitrate Er | 397 | $7,004 | $18 |
| Potassium Chloride | 172 | $6,769 | $39 |
| Carvedilol | 563 | $6,348 | $11 |
| Warfarin | 681 | $6,328 | $9 |
| Simvastatin | 542 | $6,167 | $11 |
| Inderal La | 13 | $6,017 | $463 |
| Nexium | 26 | $5,623 | $216 |
| Losartan | 285 | $5,154 | $18 |
| Vytorin | 20 | $4,811 | $241 |
| Multaq | 15 | $4,805 | $320 |
| Micardis | 15 | $4,374 | $292 |
| Dexilant | 13 | $4,296 | $330 |
| Advair Diskus | 13 | $4,267 | $328 |
| Benicar | 19 | $3,894 | $205 |
| Aciphex | 11 | $3,852 | $350 |
| Amlodipine Besylate | 412 | $3,618 | $9 |
| Valsartan-Hydrochlorothiazide | 25 | $3,456 | $138 |
| Cilostazol | 80 | $3,057 | $38 |
| Nitrostat | 128 | $2,966 | $23 |
| Lisinopril | 339 | $2,782 | $8 |
| Pantoprazole | 84 | $2,504 | $30 |
| Diltiazem 24hr Cd | 77 | $2,296 | $30 |
| Benazepril | 156 | $2,262 | $15 |
| Nifedipine Er | 24 | $2,187 | $91 |
| Amiodarone | 101 | $2,078 | $21 |
| Omeprazole | 161 | $2,037 | $13 |
| Diltiazem Er | 38 | $2,019 | $53 |
| Furosemide | 331 | $2,013 | $6 |
| Pioglitazone | 12 | $1,990 | $166 |
| Bystolic | 18 | $1,888 | $105 |
| Metoprolol | 239 | $1,873 | $8 |
| Levothyroxine | 180 | $1,780 | $10 |
| Coumadin | 32 | $1,731 | $54 |
| Diltiazem 24hr Er | 55 | $1,626 | $30 |
| Hydrochlorothiazide | 199 | $1,463 | $7 |
| Flecainide Acetate | 13 | $1,445 | $111 |
| Hydralazine | 46 | $1,441 | $31 |
| Pravastatin | 77 | $1,303 | $17 |
| Atenolol | 168 | $1,232 | $7 |
| Fenofibrate | 22 | $1,088 | $49 |
| Midodrine | 11 | $1,085 | $99 |
| Spironolactone | 94 | $991 | $11 |
| Pentoxifylline | 36 | $988 | $27 |
| Cartia Xt | 21 | $948 | $45 |
| Digox | 91 | $931 | $10 |
| Losartan-Hydrochlorothiazide | 60 | $866 | $14 |
| Proair Hfa | 16 | $754 | $47 |
| Verapamil Er | 34 | $733 | $22 |
| Captopril | 55 | $711 | $13 |
| Klor-Con 10 | 23 | $706 | $31 |
| Diltiazem | 53 | $666 | $13 |
| Quinapril | 31 | $636 | $21 |
| Donepezil | 15 | $461 | $31 |
| Primidone | 16 | $457 | $29 |
| Allopurinol | 56 | $433 | $8 |
| Klor-Con 8 | 19 | $421 | $22 |
| Hydrocodone-Acetaminophen | 21 | $416 | $20 |
| Klor-Con M20 | 21 | $402 | $19 |
| Metformin | 31 | $360 | $12 |
| Ramipril | 26 | $347 | $13 |
| Enalapril Maleate | 33 | $333 | $10 |
| Finasteride | 16 | $331 | $21 |
| Ranitidine | 29 | $327 | $11 |
| Klor-Con M10 | 13 | $324 | $25 |
| Azithromycin | 34 | $323 | $9 |
| Doxazosin Mesylate | 18 | $322 | $18 |
| Clonidine | 39 | $317 | $8 |
| Cephalexin | 18 | $306 | $17 |
| Metolazone | 14 | $297 | $21 |
| Bumetanide | 13 | $287 | $22 |
| Isosorbide Mononitrate | 23 | $233 | $10 |
| Famotidine | 15 | $223 | $15 |
| Acetaminophen-Codeine | 21 | $210 | $10 |
| Alprazolam | 33 | $205 | $6 |
| Triamterene-Hctz | 15 | $192 | $13 |
| Zolpidem | 13 | $183 | $14 |
| Temazepam | 28 | $157 | $6 |
| Glyburide | 18 | $157 | $9 |
| Tamsulosin | 12 | $135 | $11 |
| Digoxin | 15 | $108 | $7 |
| Verapamil | 13 | $104 | $8 |
| Propranolol | 12 | $87 | $7 |
Money from drug and device companies
$2,146 in 2025
| 2025 | 16 | 58 | None | $2,146 |
| 2024 | 21 | 79 | None | $2,436 |
| 2023 | 21 | 46 | None | $1,651 |
| 2022 | 21 | 111 | None | $3,160 |
| 2021 | 15 | 30 | None | $1,204 |
| 2020 | 7 | 9 | None | $187 |
| 2019 | 22 | 95 | None | $2,918 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $831 | 8 payments
|
| Novartis Pharmaceuticals | Leqvio | $251 | 11 payments
|
| Edwards Lifesciences | Pascal | $239 | 3 payments
|
| Amgen | Repatha | $199 | 12 payments
|
| Pfizer | Vyndaqel | $160 | 8 payments
|
| Organogenesis | Via Matrix | $123 | 1 payment
|
See all 58 published payments
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-17 | Kerendia | $23 |
| Amgen | Meals · 2025-12-16 | Repatha | $22 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-10 | Jardiance | $22 |
| Novartis Pharmaceuticals | Meals · 2025-12-03 | Leqvio | $14 |
| Pfizer | Meals · 2025-10-27 | Vyndaqel | $25 |
| Biotronik | Meals · 2025-10-16 | Amvia Edge | $76 |
| Amgen | Meals · 2025-10-15 | Repatha | $13 |
| Novartis Pharmaceuticals | Meals · 2025-10-08 | Leqvio | $20 |
| Edwards Lifesciences | Meals · 2025-09-30 | Pascal | $95 |
| Amgen | Meals · 2025-09-25 | Repatha | $10 |
| Amgen | Meals · 2025-09-11 | Repatha | $20 |
| Novartis Pharmaceuticals | Meals · 2025-09-09 | Leqvio | $14 |
| Novartis Pharmaceuticals | Meals · 2025-09-09 | Leqvio | $14 |
| Novartis Pharmaceuticals | Meals · 2025-08-28 | Leqvio | $17 |
| Novartis Pharmaceuticals | Meals · 2025-08-28 | Leqvio | $17 |
| Edwards Lifesciences | Meals · 2025-08-21 | Pascal | $133 |
| Pfizer | Meals · 2025-08-21 | Vyndaqel | $26 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-13 | Kerendia | $22 |
| Amgen | Meals · 2025-08-12 | Repatha | $19 |
| Novartis Pharmaceuticals | Meals · 2025-08-06 | Leqvio | $27 |
| Organogenesis | Meals · 2025-07-24 | Via Matrix | $123 |
| Amgen | Meals · 2025-07-16 | Repatha | $23 |
| Pfizer | Meals · 2025-07-16 | Eliquis | $17 |
| Pfizer | Meals · 2025-07-02 | Vyndaqel | $22 |
| Amgen | Meals · 2025-06-19 | Repatha | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-06-17 | Lifevest | $19 |
| Novo Nordisk | Meals · 2025-06-11 | Wegovy | $18 |
| Edwards Lifesciences | Meals · 2025-05-22 | Pascal | $11 |
| Amgen | Meals · 2025-05-22 | Repatha | $16 |
| Bard Peripheral Vascular | Meals · 2025-05-20 | Rotarexs 6 F X 135 Cm | $21 |
| Shockwave Medical | Meals · 2025-05-15 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $54 |
| Amgen | Meals · 2025-05-09 | Repatha | $4 |
| Novartis Pharmaceuticals | Meals · 2025-05-07 | Leqvio | $22 |
| Pfizer | Meals · 2025-05-06 | Vyndaqel | $20 |
| Lilly USA | Meals · 2025-05-02 | Zepbound | $23 |
| Amgen | Meals · 2025-04-23 | Repatha | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-16 | Farxiga | $17 |
| Merck Sharp & Dohme | Meals · 2025-04-15 | Verquvo | $25 |
| Pfizer | Meals · 2025-04-09 | Vyndaqel | $15 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-02 | Jardiance | $14 |
| Pfizer | Meals · 2025-03-26 | Eliquis | $15 |
| Amgen | Meals · 2025-03-19 | Repatha | $22 |
| Shockwave Medical | Meals · 2025-03-18 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $27 |
| Merck Sharp & Dohme | Meals · 2025-03-13 | Verquvo | $17 |
| Shockwave Medical | Meals · 2025-03-12 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $133 |
| Novartis Pharmaceuticals | Meals · 2025-03-06 | Leqvio | $65 |
| Novartis Pharmaceuticals | Meals · 2025-03-05 | Leqvio | $25 |
| Shockwave Medical | Meals · 2025-02-28 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $26 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-25 | Adempas | $15 |
| Pfizer | Meals · 2025-02-18 | Vyndaqel | $20 |
| Shockwave Medical | Meals · 2025-02-07 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $49 |
| Shockwave Medical | Meals · 2025-02-07 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $161 |
| Shockwave Medical | Meals · 2025-02-07 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $50 |
| Shockwave Medical | Travel · 2025-02-07 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $330 |
| Novartis Pharmaceuticals | Meals · 2025-02-04 | Leqvio | $15 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-01-22 | Jardiance | $14 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-14 | Camzyos | $16 |
| Amgen | Meals · 2025-01-09 | Repatha | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,436
| Kiniksa Pharmaceuticals International plc | Arcalyst | $383 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $272 | 8 payments
|
| Novo Nordisk | Wegovy | $244 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $202 | 3 payments
|
| Amgen | Repatha | $193 | 11 payments
|
| Kestra Medical Technology Services | Assure Wcd | $146 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $134 | 7 payments
|
| Impulse Dynamics (USA) | Optimizer | $129 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $117 | 3 payments
|
| Lilly USA | Mounjaro | $109 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $93 | 5 payments
|
| Merck Sharp & Dohme | Verquvo | $79 | 4 payments
|
| United Therapeutics | None | $75 | 1 payment
|
| Pfizer | Eliquis | $45 | 2 payments
|
| Heartflow | Ffrct | $43 | 2 payments
|
| Scpharmaceuticals | Furoscix | $38 | 2 payments
|
| Lexicon Pharmaceuticals | None | $30 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Adempas | $29 | 2 payments
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $29 | 1 payment
|
| Abbott Laboratories | Cardiomems | $26 | 1 payment
|
| Esperion Therapeutics | Nexletol | $19 | 1 payment
|
2023: $1,651
| Impulse Dynamics (USA) | Optimizer | $202 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $192 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $178 | 2 payments
|
| Pfizer | Vyndaqel | $173 | 7 payments
|
| Abiomed | Impella | $132 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $122 | 6 payments
|
| Actelion Pharmaceuticals US | Uptravi | $90 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $90 | 5 payments
|
| Inspire Medical Systems | Inspire | $90 | 1 payment
|
| Amgen | Repatha | $76 | 4 payments
|
| Abbott Laboratories | Gallant | $69 | 1 payment
|
| Terumo Medical | None | $54 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $38 | 2 payments
|
| Regeneron Healthcare Solutions | Evkeeza | $24 | 1 payment
|
| Kestra Medical Technology Services | Assure Wcd | $24 | 1 payment
|
| Medtronic | Reveal Linq | $21 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $17 | 1 payment
|
| HeartFlow | Ffrct | $17 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $16 | 1 payment
|
| Lexicon Pharmaceuticals | Inpefa | $14 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $13 | 1 payment
|
2022: $3,160
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $601 | 13 payments
|
| Medtronic | Reveal Linq | $319 | 6 payments
|
| Merck Sharp & Dohme | Verquvo | $306 | 9 payments
|
| Janssen Pharmaceuticals | Xarelto | $290 | 15 payments
|
| Impulse Dynamics (USA) | Optimizer | $285 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $200 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $199 | 7 payments
|
| Actelion Pharmaceuticals US | Opsumit | $172 | 8 payments
|
| Abbott Laboratories | 2nd Gen Centrimag Primary Console | $142 | 3 payments
|
| Baxter Healthcare | None | $128 | 2 payments
|
| Novartis Pharmaceuticals | Leqvio | $116 | 7 payments
|
| Pfizer | Eliquis | $103 | 5 payments
|
| Novo Nordisk | Rybelsus | $82 | 5 payments
|
| Esperion Therapeutics | Nexletol | $48 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Adempas | $36 | 2 payments
|
| Amgen | Repatha | $35 | 2 payments
|
| Chiesi USA | Kengreal | $35 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $21 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $15 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $13 | 1 payment
|
| AngioDynamics | Alphavac | $13 | 1 payment
|
2021: $1,204
| Medtronic | Micra | $290 | 7 payments
|
| Abbott Laboratories | Cardiomems Hf System | $202 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $134 | 3 payments
|
| Vifor Pharma | Veltassa | $103 | 1 payment
|
| Bard Peripheral Vascular | None | $101 | 1 payment
|
| Esperion Therapeutics | Nexlizet | $93 | 1 payment
|
| Abiomed | Impella | $62 | 1 payment
|
| Novo Nordisk | Ozempic | $54 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Verquvo | $34 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $31 | 2 payments
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $26 | 1 payment
|
| Pfizer | Eliquis | $21 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $18 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $17 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $16 | 1 payment
|
2020: $187
| Abbott Laboratories | Heartmate 3 Left Ventricular Dev | $67 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $39 | 1 payment
|
| Pfizer | Chantix | $20 | 1 payment
|
| Philips Electronics North America | Igt D Peripheral | $17 | 1 payment
|
| Acist Medical Systems | Cvi Consumables | $16 | 1 payment
|
| Boston Scientific | General - Atherectomy | $15 | 1 payment
|
| Medtronic Vascular | Reveal Linq | $13 | 1 payment
|
2019: $2,918
| Medtronic Vascular | Resolute | $871 | 23 payments
|
| Janssen Pharmaceuticals | Xarelto | $280 | 12 payments
|
| Abiomed | Legacy | $244 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $231 | 5 payments
|
| Boston Scientific | Emblem | $208 | 5 payments
|
| Pfizer | Vyndaqel | $175 | 10 payments
|
| Abbott Laboratories | Mitra Clip System | $165 | 6 payments
|
| Novartis Pharmaceuticals | Entresto | $126 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $125 | 4 payments
|
| Cook Medical | Cook Medical Micropuncture | $99 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $74 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $63 | 4 payments
|
| Philips Electronics North America | Trilogy 100 | $42 | 2 payments
|
| Aziyo Biologics | Ecm Patch,Pouch | $39 | 2 payments
|
| Sanofi-Aventis U.S. | Praluent | $35 | 2 payments
|
| Osprey Medical | Dyevert | $27 | 1 payment
|
| Gilead Sciences | None | $23 | 1 payment
|
| Acist Medical Systems | Cvi Systems | $22 | 2 payments
|
| Astellas Pharma US | Lexiscan | $21 | 1 payment
|
| ShockWave Medical | Vascular Lithotripsy | $21 | 1 payment
|
| Amarin Pharma | Vascepa | $15 | 1 payment
|
| Amgen | Repatha | $12 | 1 payment
|
Checkups this office reported
10 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 68%That's more than half. | 828 |
| Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery PatientsAs Medicare defines this measure | 0% | 173 |
| Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk PatientsAs Medicare defines this measure | 0% | 173 |
| Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF <= 40%)As Medicare defines this measure | 82% | 62 |
| Coronary Artery Disease (CAD): Antiplatelet TherapyAs Medicare defines this measure | 78% | 452 |
| Medications listed in the chartVisits where the current medication list was documented | 93%That's most of the people this applied to. | 1,650 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 862 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 30% | 374 |
See the other 2 measures
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 85%That's most of the people this applied to. | 871 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 98%That's most of the people this applied to. | 1,287 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
Professional record
- NPI
- 1811906894
- Licence
- CA 00A299270
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A299270
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 2800 N California St, Ste 14, Stockton, CA, 95204
- NPI first listed
- 2006-08-07
- NPI last updated
- 2014-01-22
This is when the NPI record was last certified, not a medical board exam.